Early research (Phase 1)Study completedNCT01968070What this trial is testingLY3127760 in Healthy ParticipantsWho this might be right forHealthy Volunteers Eli Lilly and Company 80
Early research (Phase 1)Study completedNCT06089837What this trial is testingSafety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy SubjectsWho this might be right forHealthy Subjects EicOsis Human Health Inc. 16
Not applicableStudy completedNCT01098786What this trial is testingDrug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA VaccineWho this might be right forSwine-Origin Influenza A H1N1 Virus Novartis Vaccines 556
Early research (Phase 1)UnknownNCT06079541What this trial is testingPhase 1 Clinical Study of JMKX003142 TabletsWho this might be right forSafety and Tolerability Jemincare 106
Early research (Phase 1)Study completedNCT04268394What this trial is testingEvaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677Who this might be right forHealthy Volunteer Celgene 48
Early research (Phase 1)Study completedNCT07032272What this trial is testingInvestigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.Who this might be right forAutoimmune and Chronic Inflammatory Diseases Novartis Pharmaceuticals 16
Early research (Phase 1)Study completedNCT06037395What this trial is testingPhase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male SubjectsWho this might be right forHealthy Subject Celltrion 154
Not applicableStudy completedNCT07109453What this trial is testingTo Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human SubjectsWho this might be right forNormalSensitive Skin NovoBliss Research Pvt Ltd 26
Early research (Phase 1)Study completedNCT01007383What this trial is testingLEO 27847 - A Study in Healthy Male SubjectsWho this might be right forHealthy LEO Pharma 48
Early research (Phase 1)Study completedNCT05496205What this trial is testingA SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy VolunteersWho this might be right forOsteoarthritisPainPost Herpetic Neuralgia+3 more iN Therapeutics Co., Ltd. 104
Testing effectiveness (Phase 2)Looking for participantsNCT06166056What this trial is testingInvestigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With BronchiectasisWho this might be right forBronchiectasis Chiesi Farmaceutici S.p.A. 45
Early research (Phase 1)Study completedNCT00495729What this trial is testing15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.Who this might be right forSleep Initiation and Maintenance Disorders GlaxoSmithKline 36
Early research (Phase 1)Study completedNCT01155531What this trial is testingSafety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy SubjectsWho this might be right forObesity Theracos 40
Early research (Phase 1)Study completedNCT00684502What this trial is testingStudy to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy SubjectsWho this might be right forPain AstraZeneca 110
Early research (Phase 1)Study completedNCT05476094What this trial is testingEvaluate Pharmacokinetic/Pharmacodynamic and Safety/Tolerability of AYP-101 in Healthy SubjectsWho this might be right forHealthy SubjectsSubmental Fat AMIpharm Co., Ltd. 26
Early research (Phase 1)Study completedNCT01818869What this trial is testingTo Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy SubjectsWho this might be right forSafety,Tolerability,Healthy Subjects AstraZeneca 8
Large-scale testing (Phase 3)Study completedNCT01418937What this trial is testingSafety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 StudyWho this might be right forInfections, Papillomavirus GlaxoSmithKline 164
Early research (Phase 1)Study completedNCT03647228What this trial is testingA Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic FibrosisWho this might be right forHealthy SubjectsCystic Fibrosis Ionis Pharmaceuticals, Inc. 98
Early research (Phase 1)Study completedNCT01263236What this trial is testingLY2940094 in Major Depressive DisorderWho this might be right forMajor Depressive Disorder BlackThorn Therapeutics, Inc. 66
Early research (Phase 1)Study completedNCT07337044What this trial is testingEvaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Subjects After Subcutaneous Injection of TISA-818-InjWho this might be right forHealthy Subjects EnliTISA (Shanghai) Pharmaceutical Co., Ltd. 49